Adjunctive Methylene Blue for Immunotherapy-related CRS and ICANS: Phase I Study
Clinical trial NCT07169487 · RECRUITING
Trial details
- NCT number
- NCT07169487
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-28
- Primary completion
- 2028-06-28
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.